ARCHIVES

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

This article is from The Cancer Letter archive.

Vol. 06 No. 06 | February 8, 1980

Download PDF Visit The Full Archive

Related Articles

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974

NIH Seeking Nominations for Review Committees

February 23, 1979

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors

April 25, 1980